AgeX Therapeutics Q2 EPS $(0.09) Down From $(0.06) YoY, Sales $411K Up From $380K YoY

AgeX Therapeutics (AMEX:AGE) reported quarterly losses of $(0.09) per share. This is a 50 percent decrease over losses of $(0.06) per share from the same period last year. The company reported $411 thousand in sales

Benzinga · 11/14/2019 21:03

AgeX Therapeutics (AMEX:AGE) reported quarterly losses of $(0.09) per share. This is a 50 percent decrease over losses of $(0.06) per share from the same period last year. The company reported $411 thousand in sales this quarter. This is a 8.16 percent increase over sales of $380 thousand the same period last year.